Back to all studies
😴
Phase 1
Sleep
in-person
PrP-targeting siRNA Safety & Mechanism Study
Sponsored by Broad Institute of MIT and Harvard
Compensation
$500–$2,500
Duration
3 months
Location
Multi-State
About this study
The purpose of this trial is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamic impact of PrP-siRNA in symptomatic prion disease patients.
Who can participate
- • Adults aged 18–99
- • All genders welcome
- • Diagnosed with or experiencing prion disease
- • Able to attend in-person clinic visits
What's included
- • Compensation up to $2,500
- • All study-related medical care at no cost
- • Lab work, screenings, and physician consultations
- • Study medication or treatment provided
IRB-approved study. Free to apply. Your information is kept confidential.
Ready to Find a Paid Study?
Join over 100,000 people who have been matched with clinical studies. It's free, fast, and could change your life.